46 results on '"Kim Rathana"'
Search Results
2. Inotuzumab Ozogamicin and Low-Intensity Chemotherapy in Older Patients With Newly Diagnosed CD22+ Philadelphia Chromosome–Negative B-Cell Precursor Acute Lymphoblastic Leukemia
3. Nilotinib with or without cytarabine for Philadelphia-positive acute lymphoblastic leukemia
4. Lymphopenia confers poorer prognosis in Myelodysplastic Syndromes with very low and low IPSS-M
5. Myelodysplastic Syndrome associated TET2 mutations affect NK cell function and genome methylation
6. Genetic subtypes of B-cell acute lymphoblastic leukemia in adults
7. Genetic alterations and MRD refine risk assessment for KMT2A-rearranged B-cell precursor ALL in adults: a GRAALL study
8. IL-7 receptor expression is frequent in T-cell acute lymphoblastic leukemia and predicts sensitivity to JAK inhibition
9. Clonal hematopoiesis driven by chromosome 1q/MDM4 trisomy defines a canonical route toward leukemia in Fanconi anemia
10. Prognostic impact of DDX41 germline mutations in intensively treated acute myeloid leukemia patients: an ALFA-FILO study
11. Concurrent CDX2 cis-deregulation and UBTF::ATXN7L3 fusion define a novel high-risk subtype of B-cell ALL
12. Inotuzumab Ozogamicin and Low-Intensity Chemotherapy in Older Patients With Newly Diagnosed CD22 + Philadelphia Chromosome–Negative B-Cell Precursor Acute Lymphoblastic Leukemia.
13. Hematopoietic differentiation at single-cell resolution in NPM1-mutated AML
14. Significance of Measurable Residual Disease in Adult Philadelphia Chromosome–Positive ALL: A GRAAPH-2014 Study.
15. A multiparametric niche-like drug screening platform in acute myeloid leukemia
16. Blinatumomab consolidation for adult B-cell acute lymphoblastic leukemia in first and second complete remission
17. P319: IL7-RECEPTOR EXPRESSION IS FREQUENT IN T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA AND PREDICTS SENSITIVITY TO JAK-INHIBITION
18. P315: TP53 ALTERATIONS AND MRD REFINE PROGNOSIS OF ADULT KMT2A-REARRANGED B-ALL
19. Adult Low-Hypodiploid Acute Lymphoblastic Leukemia Emerges from Preleukemic TP53-Mutant Clonal Hematopoiesis.
20. Adult Low-Hypodiploid Acute Lymphoblastic Leukemia Emerges from Preleukemic TP53-Mutant Clonal Hematopoiesis
21. UBTF tandem duplications define a distinct subtype of adult de novo acute myeloid leukemia
22. IL7-receptor expression is frequent in T-cell acute lymphoblastic leukemia and predicts sensitivity to JAK-inhibition
23. Supplementary Figures S1-S10 from Adult Low-Hypodiploid Acute Lymphoblastic Leukemia Emerges from Preleukemic TP53-Mutant Clonal Hematopoiesis
24. Supplementary Tables S1-S11 from Adult Low-Hypodiploid Acute Lymphoblastic Leukemia Emerges from Preleukemic TP53-Mutant Clonal Hematopoiesis
25. Data from Adult Low-Hypodiploid Acute Lymphoblastic Leukemia Emerges from Preleukemic TP53-Mutant Clonal Hematopoiesis
26. Allogeneic transplantation in acute myelogenous leukemia: a comprehensive single institution's experience
27. Adult Low-Hypodiploid Acute Lymphoblastic Leukemia Emerges from PreleukemicTP53-Mutant Clonal Hematopoiesis
28. 3041 – THE ROLE OF CLONAL HEMATOPOIESIS IN ADULT ACUTE LYMPHOBLASTIC LEUKEMIA
29. Blinatumomab during Consolidation in High-Risk Philadelphia Chromosome (Ph)-Negative B-Cell Precursor (BCP) Acute Lymphoblastic Leukemia (ALL) Adult Patients: A Two-Cohort Comparison within the Graall-2014/B Study
30. Fractionated Inotuzumab Ozogamicin Combined with Low-Intensity Chemotherapy in Older Patients with Newly Diagnosed CD22+ Philadelphia Chromosome (Ph)-Negative B-Cell Precursor (BCP) Acute Lymphoblastic Leukemia (ALL): Results of the EWALL-INO Study
31. Clonal evolution in hereditary thrombocytosis with MPL T487A mutation
32. Clinical, pathological, and molecular features of myelodysplasia cutis
33. UBTFtandem duplications define a distinct subtype of adult de novo acute myeloid leukemia
34. Exploring the Heterogeneity of Response to Blinatumomab in High-Risk Philadelphia-Negative B-Cell Precursor Acute Lymphoblastic Leukemia: An Analysis from the QUEST Sub-Study of the Graall-2014/B Trial
35. The Splicing-Associated Network PAK1-Clk-SRRM1 Is a Critical Vulnerability to Overcome Chemoresistance in Acute Myeloid Leukemia
36. Genetic subtypes of B-cell acute lymphoblastic leukemia in adults
37. Concurrent CDX2 cis-deregulation and UBTF::ATXN7L3fusion define a novel high-risk subtype of B-cell ALL
38. Uncovering new layers of Ph+ALL biology
39. Uncovering new layers of Ph+ ALL biology
40. Clonal evolution in hereditary thrombocytosis with MPL T487A mutation.
41. Prognostic impact of DDX41germline mutations in intensively treated acute myeloid leukemia patients: an ALFA-FILO study
42. Clonal hematopoiesis driven by chromosome 1q/MDM4trisomy defines a canonical route toward leukemia in Fanconi anemia
43. Prospective feasibility of a minimal BH3 profiling assay in acute myeloid leukemia.
44. Differential activation of basal and IL-7-induced PI3K/Akt/ mTOR and JAK/STAT5 signaling distinguishes pediatric from adult acute lymphoblastic leukemia.
45. Adult Low-Hypodiploid Acute Lymphoblastic Leukemia Emerges from Preleukemic TP53-Mutant Clonal Hematopoiesis.
46. Ikaros deficiency is associated with aggressive BCR-ABL1 B-cell precursor acute lymphoblastic leukemia independent of the lineage and developmental origin.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.